Corrigendum: No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank

Corrigendum: No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank

Bibliographic Details
Main Authors:	Jingjing Tu, Ying Xu, Xu Guo, Jiayu Zhang, Duo Xu, Liyuan Han, Yue Wang, Boya Zhang, Hongpeng Sun
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Medicine
Subjects:	plasma cystatin C cardiovascular disease stroke myocardial infarction Mendelian randomization genetic risk
Online Access:	https://www.frontiersin.org/articles/10.3389/fmed.2023.1361467/full

Similar Items

No causal association between plasma cystatin C and cardiovascular diseases: Mendelian randomization analyses in UK biobank
by: Jingjing Tu, et al.
Published: (2023-08-01)

Causal association between cystatin C and diabetic retinopathy: A two‐sample Mendelian randomization study
by: Yimeng Ruan, et al.
Published: (2024-11-01)

Causal Effects of Genetically Predicted Cystatin C on Osteoporosis: A Two-Sample Mendelian Randomization Study
by: Jiaqin Yuan, et al.
Published: (2022-05-01)

Mendelian randomization study supports the causal association between serum cystatin C and risk of diabetic nephropathy
by: Baiyu Feng, et al.
Published: (2022-11-01)

Serum cystatin C and stroke risk: a national cohort and Mendelian randomization study
by: Yitian Qi, et al.
Published: (2024-04-01)

Nonlinear causal effects of estimated glomerular filtration rate on myocardial infarction risks: Mendelian randomization study
by: Sehoon Park, et al.
Published: (2022-02-01)

Role for Cystatin C–Based Risk Stratification for Patients After Acute Coronary Syndrome in the Era of High Sensitivity Cardiac Troponin Assays
by: Federica Latta, et al.
Published: (2018-10-01)

Cystatin C Predicts Incident Cardiovascular Disease in Twins
by: Johannes Arpegård, et al.
Published: (2016-06-01)

Prognostic ability of cystatin C and homocysteine plasma levels for long-term outcomes in very old acute myocardial infarction patients
by: Fu Z, et al.
Published: (2018-07-01)

Causal Relationships between Lymphocyte Subsets and Risk of Coronary Artery Disease: A Two-Sample Mendelian Randomization Study
by: Zhao Ma, et al.
Published: (2024-09-01)

Cystatin C as a Predictor of Major Adverse Cardiovascular Event in Patients with Acute Myocardial Infarction Without Cardiogenic Shock and Renal Impairment After Coronary Intervention
by: Wasyanto T, et al.
Published: (2023-06-01)

Unraveling genetic causality between metformin and myocardial infarction on the basis of Mendelian randomization
by: Yongru Zhuang, et al.
Published: (2024-05-01)

Causal Effects of Air Pollution, Noise, and Shift Work on Unstable Angina and Myocardial Infarction: A Mendelian Randomization Study
by: Qiye Ma, et al.
Published: (2024-12-01)

Investigating the causal interplay between sleep traits and risk of acute myocardial infarction: a Mendelian randomization study
by: Nikhil Arora, et al.
Published: (2023-10-01)

Educational inequality in multimorbidity: causality and causal pathways. A mendelian randomisation study in UK Biobank
by: Teri-Louise North, et al.
Published: (2023-08-01)

Exploring the causality of appendectomy and ischaemic heart disease: a Mendelian randomization study and meta-analysis
by: Shuai Wang, et al.
Published: (2024-08-01)

Cystatin C- and Creatinine-based Estimated GFR Differences: Prevalence and Predictors in the UK Biobank
by: Debbie C. Chen, et al.
Published: (2024-04-01)

Therapeutic efficacy of Schistosoma japonicum cystatin on sepsis-induced cardiomyopathy in a mouse model
by: Shifang Gao, et al.
Published: (2020-05-01)

Serum cystatin C is associated with the prognosis in acute myocardial infarction patients after coronary revascularization: a systematic review and meta-analysis
by: Jun Chen, et al.
Published: (2022-04-01)

Acute response of exercise rehabilitation with electrical stimulation on serum levels antigen, carbohydrate 125 (CA-125) and cystatin (Cys-C) in myocardial infarction rats
by: MalekiPooya M, et al.
Published: (2022-06-01)

Causal associations between blood pressure and the risk of myocardial infarction: A bidirectional Mendelian randomization study
by: Zhi-Qiang Yang, et al.
Published: (2022-11-01)

Cystatin C: A prognostic marker after myocardial infarction in patients without chronic kidney disease
by: Leila Abid, et al.
Published: (2016-07-01)

Evaluation of serum procathepsin B, cystatin B and cystatin C as possible biomarkers of ovarian cancer
by: Elena A. Gashenko, et al.
Published: (2013-08-01)

Cystatin C-based estimated glomerular filtration rate after percutaneous coronary intervention in the prediction of inhospital mortality in acute myocardial infarction
by: K. V. Protasov, et al.
Published: (2022-01-01)

Wnt 3a Protects Myocardial Injury in Elderly Acute Myocardial Infarction by Inhibiting Serum Cystatin C/ROS-Induced Mitochondrial Damage
by: Jian Shen, et al.
Published: (2022-07-01)

Lower creatinine-to-cystatin c ratio associated with increased risk of incident amyotrophic lateral sclerosis in the prospective UK biobank cohort
by: Zhuoya Wang, et al.
Published: (2024-11-01)

Bidirectional two-sample Mendelian randomization study of causality between rheumatoid arthritis and myocardial infarction
by: Hao-Yang Guo, et al.
Published: (2022-12-01)

Cysteine proteinases and cystatins
by: Adeliana S. Oliveira, et al.
Published: (2003-01-01)

The cystatin superfamily of proteinase inhibitors /
by: 357692 Taupin, Philippe
Published: (c200)

Clinical value of combined plasma brain natriuretic peptide and serum cystatin C measurement on the prediction of heart failure in patients after acute myocardial infarction
by: Rui Liu, et al.
Published: (2023-09-01)

Osteoarthritis, coronary artery disease, and myocardial infarction: A mendelian randomization study
by: Huiqing Xu, et al.
Published: (2022-08-01)

Genetically predicted hypothyroidism, thyroid hormone treatment, and the risk of cardiovascular diseases: a mendelian randomization study
by: Shuaidan Zhang, et al.
Published: (2024-09-01)

Causality of anti-Helicobacter pylori IgG levels on myocardial infarction and potential pathogenesis: a Mendelian randomization study
by: Qiubo Wang, et al.
Published: (2023-09-01)

No causal effect of tea consumption on cardiovascular diseases: A two-sample Mendelian randomization study
by: Lu Chen, et al.
Published: (2022-09-01)

Cystatin C as an indicator of renal damage in pre-eclampsia
by: Hellen Cássia Dos Santos Gomes, et al.
Published: (2020-07-01)

Cystatin C and sarcopenia index are associated with cardiovascular and all-cause death among adults in the United States
by: Tianbo Wang, et al.
Published: (2024-07-01)

Causal effects for genetic variants of osteoprotegerin on the risk of acute myocardial infarction and coronary heart disease: A two-sample Mendelian randomization study
by: Peng Chao, et al.
Published: (2023-03-01)

Corrigendum: Sex difference in the association between creatinine-to-cystatin C ratio and metabolic syndrome among Chinese adults
by: Jo-Hsuan Chen, et al.
Published: (2024-10-01)

CYSTATIN C AS A SCREENING BIOMARKER OF GESTATIONAL DIABETES MELLITUS
by: Sadia Israr, et al.
Published: (2020-08-01)

The regulatory role of cystatin C in autophagy and neurodegeneration
by: T. A. Korolenko, et al.
Published: (2019-07-01)